0.0106	1.0391	OMIM:231090	HYDATIDIFORM MOLE	NLRP7	199713
0.0106	1.0391	OMIM:305690	GENITOURINARY TRACT ANOMALIES		
0.0106	1.0391	OMIM:600171	GONADAL AGENESIS		
0.0106	1.0391	OMIM:191600	URETER, CANCER OF		
0.0106	1.0391	OMIM:149600	LABIA MINORA, INCOMPLETE ADHESION OF		
0.0106	1.0391	OMIM:191800	URINARY BLADDER, ATONY OF		
0.0106	0.9702	OMIM:171000	PEYRONIE DISEASE		
0.0372	2.4827	OMIM:136680	FRASIER SYNDROME	WT1	7490
0.1241	2.0651	ORPHANET:3109	MAYER-ROKITANSKY-KÃœSTER-HAUSER SYNDROME		
0.2682	1.9554	ORPHANET:2795	POLYCYSTIC OVARIES - URETHRAL SPHINCTER DYSFUNCTION		
0.3290	3.0323	OMIM:192900	VERTEBRAL HYPOPLASIA WITH LUMBAR KYPHOSIS		
0.3290	2.5055	OMIM:256370	NEPHROTIC SYNDROME, EARLY-ONSET, WITH DIFFUSE MESANGIAL SCLEROSIS	WT1	7490
0.4584	2.1260	OMIM:194072	#194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATIONSYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11P13 DELETION SYNDROME		
0.5043	3.2558	OMIM:166970	OVARIAN FIBROMATA		
0.5043	3.1019	OMIM:150699	#150699 LEIOMYOMA, UTERINE; UL	HMGA2	8091
0.5043	3.1019	OMIM:608089	ENDOMETRIAL CANCER	MSH6, MLH3, PTEN, CDH1	2956, 27030, 5728, 999
0.5043	2.7684	OMIM:614337	#614337 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4	PMS2	5395
0.5043	2.7366	OMIM:612551	#612551 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4;;END-STAGE RENAL DISEASE, NONDIABETIC, SUSCEPTIBILITY TO, INCLUDED	APOL1	8542
0.5043	2.5716	OMIM:114500	COLORECTAL CANCER	EP300, AKT1, BAX, PTPRJ, FLCN, MCC, PIK3CA, FGFR3, NRAS, CTNNB1, PDGFRL, APC, BUB1B, PTPN12, DCC, RAD54B, MLH3, AXIN2, TP53	2033, 207, 581, 5795, 201163, 4163, 5290, 2261, 4893, 1499, 5157, 324, 701, 5782, 1630, 25788, 27030, 8313, 7157
0.5043	2.5119	OMIM:612359	#612359 COWDEN-LIKE SYNDROME	SDHB	6390
